Alibaba has muscled ahead of Walmart by one important measure: its market valuation now exceeds that of the world’s largest retailer by revenues.

Alibaba, the Chinese ecommerce behemoth that listed in New York last month, has muscled ahead of Walmart by one important measure: its market valuatio(...)

Following on from Sunday’s stress test results, AIB was down by 5 per cent to 10 cents. Photograph:  Cyril Byrne

European shares rose yesterday, reversing the previous session’s dip as better-than-expected results from a number of blue-chips including pharma gro(...)

EGM tomorrow: Fyffes will hold its EGM at the Ballsbridge Hotel in  Dublin 4 to discuss its planned merger with Chiquita. Photograph: Simon Dawson/Bloomberg
For your diary

TODAY Results: Alkermes; Allergan; Amgen; Burger King Worldwide; Doosan; Merck; Seagate Technology; Twitter; TNT Express. Indicators: Irish retail sal(...)

EU antitrust regulators have approved US drugmaker Eli Lilly’s $5.4 billion takeover of Swiss peer Novartis’s animal health business. Photo: Reuters

EU antitrust regulators approved US drugmaker Eli Lilly’s $5.4 billion takeover of Swiss peer Novartis’s animal health business on Friday.The Europea(...)

Ryanair climbed 3.16 % as markets continued to react positively to its launch of a business-class service. Photograph: Rui Vieira/PA Wire

The Iseq rose by a solid 0.8 per cent yesterday, as European stocks generally advanced in the final minutes of trading after remaining little changed (...)

Sales forecasts for Novartis’s new heart failure drug are being ramped up by analysts after good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.

Sales forecasts for Novartis’s new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doct(...)

Novartis executives say the company will file for approval of the drug, LCZ696, in Europe in the first quarter of 2015. The drug could get to patients as early as next year. Photograph: Fabrice Coffrini/AFP/Getty Images

Swiss pharma group Novartis has reported striking efficacy by an experimental drug in prolonging the lives of people with heart failure in a developme(...)

Stephen Brobst: “I want to know every click and every search that led up to that purchase. . . interactions are orders of magnitude larger than the transactions. . . the interactions give you the behaviour.” Photograph: Cyril Byrne

Diversity always enhances a technology resumé, but Teradata chief technology officer Stephen Brobst brings an intriguingly eclectic mix to the tabl(...)

Zurich-listed  Nestlé, the world’s largest food company, dropped 1.5 per cent to 66.55 Swiss francs for a sixth day of losses. Photograph: EPA/Keystone/Fabrice Coffrini

European equities declined for a fourth day as the region’s two largest stocks retreated, the Zurich-listed food giant Nestlé and pharmaceutical co(...)

Michael O’Leary: under his stewardship Ryanair has offered an attractive dividend yield. Photograph: Dave Meehan

For income-hungry investors, plummeting bond yields and deposit rates over the past few years have meant they have had to look for returns elsewher(...)